Francisco O Buchting1, Kristen T Emory2, Yoonsang Kim3, Pebbles Fagan4, Lisa E Vera5, Sherry Emery3. 1. Horizons Foundation, San Francisco, California. Electronic address: franciscobuchting@outlook.com. 2. Moores Cancer Center at the University of California, San Diego, San Diego, California. 3. National Opinion Research Center at the University of Chicago, Chicago, Illinois. 4. Fay W. Boozman College of Public Health at the University of Arkansas for Medical Sciences, Little Rock, Arkansas. 5. VeraCite Inc., San Diego, California.
Abstract
INTRODUCTION: Tobacco use among transgender adults continues to be an area of research with few reported findings. The limited literature indicates higher cigarette use among transgender adults, compared with the general population. This national study is the first to report on cigarettes, cigars, and e-cigarettes by examining differences in transgender tobacco use independent of sexual orientation. METHODS: Data were collected in 2013 using a nationally cross-sectional online survey of U.S. adults (cisgender, n=17,164; transgender, n=168) and analyzed in 2015. Past 30-day tobacco use point estimates and adjusted logistic regression while controlling for false discovery rate were reported for transgender and cisgender respondents. RESULTS: Transgender adults reported higher past 30-day use of any cigarette/cigar/e-cigarette product (39.7% vs 25.1%) and current use of cigarettes (35.5% vs 20.7%), cigars (26.8% vs 9.3%), and e-cigarettes (21.3% vs 5.0%) compared with cisgender adults (all p-values ≤0.003). Transgender respondents had significantly higher odds of past 30-day tobacco product use for any cigarette/cigar/e-cigarette product (OR=1.97, 95% CI=1.25, 3.1), e-cigarettes (OR=5.15, 95% CI=3.36, 7.88), cigars (OR=3.56, 95% CI=2.27, 5.59), and cigarettes (OR=2.10, 95% CI=1.35, 3.28) versus cisgender respondents (all p-values ≤0.0035). CONCLUSIONS: Transgender adults are at higher risk for tobacco use than cisgender adults and risk of specific product use varies by gender. This is the first U.S. national study to assess differences in use of various tobacco products using questions that specifically ask for gender identity separately from sexual orientation. This study provides data that can inform targeted interventions to promote transgender health.
INTRODUCTION:Tobacco use among transgender adults continues to be an area of research with few reported findings. The limited literature indicates higher cigarette use among transgender adults, compared with the general population. This national study is the first to report on cigarettes, cigars, and e-cigarettes by examining differences in transgender tobacco use independent of sexual orientation. METHODS: Data were collected in 2013 using a nationally cross-sectional online survey of U.S. adults (cisgender, n=17,164; transgender, n=168) and analyzed in 2015. Past 30-day tobacco use point estimates and adjusted logistic regression while controlling for false discovery rate were reported for transgender and cisgender respondents. RESULTS: Transgender adults reported higher past 30-day use of any cigarette/cigar/e-cigarette product (39.7% vs 25.1%) and current use of cigarettes (35.5% vs 20.7%), cigars (26.8% vs 9.3%), and e-cigarettes (21.3% vs 5.0%) compared with cisgender adults (all p-values ≤0.003). Transgender respondents had significantly higher odds of past 30-day tobacco product use for any cigarette/cigar/e-cigarette product (OR=1.97, 95% CI=1.25, 3.1), e-cigarettes (OR=5.15, 95% CI=3.36, 7.88), cigars (OR=3.56, 95% CI=2.27, 5.59), and cigarettes (OR=2.10, 95% CI=1.35, 3.28) versus cisgender respondents (all p-values ≤0.0035). CONCLUSIONS: Transgender adults are at higher risk for tobacco use than cisgender adults and risk of specific product use varies by gender. This is the first U.S. national study to assess differences in use of various tobacco products using questions that specifically ask for gender identity separately from sexual orientation. This study provides data that can inform targeted interventions to promote transgender health.
Authors: Kristi E Gamarel; Ethan H Mereish; David Manning; Mariko Iwamoto; Don Operario; Tooru Nemoto Journal: Nicotine Tob Res Date: 2015-03-16 Impact factor: 4.244
Authors: Ahmed Jamal; Israel T Agaku; Erin O'Connor; Brian A King; John B Kenemer; Linda Neff Journal: MMWR Morb Mortal Wkly Rep Date: 2014-11-28 Impact factor: 17.586
Authors: Kristie A Taylor; Eva Sharma; Kathryn C Edwards; Michael J Halenar; Wendy Kissin; Karin A Kasza; Hannah Day; Gabriella Anic; Lisa D Gardner; Hoda T Hammad; Lynn C Hull; Maansi Bansal-Travers; Jean Limpert; Nicolette Borek; Heather L Kimmel; Wilson M Compton; Andrew Hyland; Cassandra Stanton Journal: Tob Control Date: 2020-05 Impact factor: 7.552
Authors: Phoenix Alicia Matthews; Amanda C Blok; Joseph G L Lee; Brian Hitsman; Lisa Sanchez-Johnsen; Karriem Watson; Elizabeth Breen; Raymond Ruiz; Melissa A Simon; Marian Fitzgibbon; Laura C Hein; Robert Winn Journal: Transl Behav Med Date: 2018-09-08 Impact factor: 3.046
Authors: Kristen Emory; Francisco O Buchting; Dennis R Trinidad; Lisa Vera; Sherry L Emery Journal: Nicotine Tob Res Date: 2019-03-30 Impact factor: 4.244
Authors: Erin A Vogel; Johannes Thrul; Gary L Humfleet; Kevin L Delucchi; Danielle E Ramo Journal: Health Psychol Date: 2018-11-29 Impact factor: 4.267